Dillon & Associates Inc Abb Vie Inc. Transaction History

Dillon & Associates Inc

  • $711 Million
  • Q3 2024

A detailed history of Dillon & Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Dillon & Associates Inc holds 6,914 shares of ABBV stock, worth $1.18 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
6,914
Previous 6,862 0.76%
Holding current value
$1.18 Million
Previous $1.18 Million 15.42%
% of portfolio
0.19%
Previous 0.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$163.84 - $199.33 $8,519 - $10,365
52 Added 0.76%
6,914 $1.36 Million
Q1 2024

Apr 30, 2024
BUY
$159.82 - $182.1 $32,123 - $36,602
201 Added 3.02%
6,862 $1.25 Million
Q3 2023

Nov 13, 2023
BUY
$133.59 - $154.65 $29,256 - $33,868
219 Added 3.4%
6,661 $992,000
Q2 2023

Aug 08, 2023
SELL
$132.51 - $164.9 $47,836 - $59,528
-361 Reduced 5.31%
6,442 $870,000
Q1 2023

May 02, 2023
SELL
$144.61 - $166.54 $840,617 - $968,097
-5,813 Reduced 46.08%
6,803 $1.08 Million
Q1 2023

May 01, 2023
BUY
$144.61 - $166.54 $563,545 - $649,006
3,897 Added 44.7%
12,616 $2.01 Million
Q4 2022

Feb 06, 2023
SELL
$138.31 - $165.87 $152,832 - $183,286
-1,105 Reduced 11.25%
8,719 $1.41 Million
Q3 2022

Nov 08, 2022
SELL
$134.21 - $153.93 $26,842 - $30,786
-200 Reduced 2.0%
9,824 $1.32 Million
Q2 2022

Jul 26, 2022
SELL
$137.62 - $174.96 $13,762 - $17,496
-100 Reduced 0.99%
10,024 $1.53 Million
Q1 2022

May 06, 2022
SELL
$131.98 - $163.75 $328,894 - $408,065
-2,492 Reduced 19.75%
10,124 $1.64 Million
Q4 2021

Feb 14, 2022
SELL
$107.43 - $135.93 $18,585 - $23,515
-173 Reduced 1.35%
12,616 $1.7 Million
Q3 2021

Oct 28, 2021
BUY
$106.4 - $120.78 $425 - $483
4 Added 0.03%
12,789 $1.38 Million
Q2 2021

Aug 02, 2021
SELL
$105.21 - $117.21 $10,521 - $11,721
-100 Reduced 0.78%
12,785 $1.45 Million
Q1 2021

May 10, 2021
SELL
$102.3 - $112.62 $334,827 - $368,605
-3,273 Reduced 20.26%
12,885 $1.39 Million
Q3 2020

Nov 06, 2020
BUY
$85.91 - $100.83 $8,762 - $10,284
102 Added 0.64%
16,158 $1.42 Million
Q2 2020

Jul 28, 2020
SELL
$73.37 - $98.18 $5,502 - $7,363
-75 Reduced 0.46%
16,056 $1.57 Million
Q1 2020

May 07, 2020
SELL
$64.5 - $97.79 $228,007 - $345,687
-3,535 Reduced 17.98%
16,131 $1.23 Million
Q4 2019

Feb 03, 2020
SELL
$72.13 - $90.25 $48,687 - $60,918
-675 Reduced 3.32%
19,666 $1.75 Million
Q3 2019

Oct 25, 2019
SELL
$62.98 - $75.72 $143,279 - $172,263
-2,275 Reduced 10.06%
20,341 $1.55 Million
Q2 2019

Jul 22, 2019
SELL
$65.7 - $83.98 $1.77 Million - $2.26 Million
-26,930 Reduced 54.35%
22,616 $1.65 Million
Q1 2019

May 07, 2019
SELL
$77.14 - $90.79 $4.61 Million - $5.43 Million
-59,786 Reduced 54.68%
49,546 $4.01 Million
Q4 2018

Feb 14, 2019
SELL
$77.85 - $96.01 $198,595 - $244,921
-2,551 Reduced 2.28%
109,332 $10.1 Million
Q3 2018

Nov 14, 2018
SELL
$88.91 - $98.84 $231,166 - $256,984
-2,600 Reduced 2.27%
111,883 $10.6 Million
Q2 2018

Aug 08, 2018
SELL
$89.78 - $106.23 $303,187 - $358,738
-3,377 Reduced 2.87%
114,483 $10.6 Million
Q1 2018

May 08, 2018
SELL
$92.01 - $123.21 $299,584 - $401,171
-3,256 Reduced 2.69%
117,860 $11.2 Million
Q4 2017

Feb 08, 2018
SELL
$89.56 - $98.21 $78,185 - $85,737
-873 Reduced 0.72%
121,116 $11.7 Million
Q3 2017

Nov 13, 2017
SELL
$69.85 - $89.22 $77,044 - $98,409
-1,103 Reduced 0.9%
121,989 $10.9 Million
Q2 2017

Aug 09, 2017
BUY
N/A
123,092
123,092 $8.99 Million

Others Institutions Holding ABBV

# of Institutions
3,817
Shares Held
1.25B
Call Options Held
13M
Put Options Held
10M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dillon & Associates Inc Portfolio

Follow Dillon & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email